Divarasib Plus Cetuximab for KRAS G12C–Positive Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Nat. Med. 2023 Dec 05;[EPub Ahead of Print], J Desai, G Alonso, SH Kim, A Cervantes, T Karasic, L Medina, E Shacham-Shmueli, R Cosman, A Falcon, E Gort, T Guren, E Massarelli, WH Miller, L Paz-Ares, H Prenen, A Amatu, C Cremolini, TW Kim, V Moreno, SI Ou, A Passardi, A Sacher, A Santoro, R Stec, S Ulahannan, K Arbour, P Lorusso, J Luo, MR Patel, Y Choi, Z Shi, S Mandlekar, MT Lin, S Royer-Joo, J Chang, T Jun, NV Dharia, JL Schutzman, SW HanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.